Yeh Chun-Nan, Chen Miin-Fu, Lee Wei-Chen, Jeng Long-Bin
Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.
J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178.
The objective of this investigation was to study the clinicopathological factors influencing long-term outcome of hepatocellular carcinoma (HCC) with liver cirrhosis in patients undergoing hepatectomy. Liver cirrhosis, especially the macronodular variety, has been found in up to 90% of patients with HCC. In Asia, the incidence of liver cirrhosis in patients with HCC who had undergone hepatic resection varies from 42.5% to 73.8%. However, the optimal surgical approach for HCC patients with cirrhosis is less clearly defined. Resection of the cirrhotic liver is challenging and remains controversial in the treatment of HCC.
This study retrospectively analyzed the surgical outcomes of HCC concomitant with liver cirrhosis in 218 patients who underwent hepatic resection between 1986 and 1998. Post-resection prognostic factors were assessed using a univariate log-rank test and a multivariate Cox proportional hazards model.
The overall postoperative complication rate was 15.6%, while the surgical mortality rate was 8.8%. Meanwhile, the 1-, 3-, and 5-year disease-free survival rates were 50.9%, 33.98%, and 27.03%, respectively, and. the overall cumulative survival rates at 1, 3, and 5 years were 63.14%, 41.88%, and 31.83%, respectively. Applying Cox's multivariate proportional hazard model indicated that significant adverse prognostic indicators included elevated alkaline phosphatase value, tumor size >2 cm, presence of satellite lesions, and vascular invasion.
This investigation found that overall survival for HCC patients concomitant with liver cirrhosis who underwent hepatic resection should be stratified on the basis of the high value of alkaline phosphatase, tumor size, satellite lesions, and vascular invasion.
本研究的目的是探讨影响接受肝切除术的肝硬化肝细胞癌(HCC)患者长期预后的临床病理因素。高达90%的HCC患者伴有肝硬化,尤其是大结节型。在亚洲,接受肝切除的HCC患者中肝硬化的发生率在42.5%至73.8%之间。然而,对于伴有肝硬化的HCC患者,最佳手术方式尚不清楚。切除肝硬化肝脏具有挑战性,在HCC治疗中仍存在争议。
本研究回顾性分析了1986年至1998年间接受肝切除的218例伴有肝硬化的HCC患者的手术结果。采用单因素对数秩检验和多因素Cox比例风险模型评估切除术后的预后因素。
术后总体并发症发生率为15.6%,手术死亡率为8.8%。同时,1年、3年和5年无病生存率分别为50.9%、33.98%和27.03%,1年、3年和5年总体累积生存率分别为63.14%、41.88%和31.83%。应用Cox多因素比例风险模型显示,显著的不良预后指标包括碱性磷酸酶值升高、肿瘤大小>2 cm、存在卫星灶和血管侵犯。
本研究发现,对于接受肝切除的伴有肝硬化的HCC患者,应根据碱性磷酸酶值、肿瘤大小、卫星灶和血管侵犯情况对总体生存率进行分层。